Thursday, February 16, 2012
Evotec AG and IR Pharma today announced that they have entered into an exclusive strategic alliance to provide integrated drug discovery solutions to Pharmaceutical and Biotech companies in the field of Respiratory Diseases.
Thursday, February 16, 2012
Catalent Pharma Solutions, a leading global drug delivery technology company, and NewMarket Pharmaceuticals LLC have entered into an agreement to jointly formulate and develop a portfolio of products for treating production and companion animals ...
Thursday, February 16, 2012
Ockham, a leading, global full-service contract research organization (CRO) with a focus in oncology, today announces it has completed the acquisition of Nexus Oncology. The transaction also provides Ockham with an institutional investment partner.
Tuesday, February 07, 2012
BASi has opened its new Discovery Center, located at its corporate headquarters in the Purdue Research Park of West Lafayette. The purpose-built facility is designed to provide pharmaceutical and biotech companies with the information they need to ...
Wednesday, February 08, 2012
INC Research , LLC, a therapeutically focused clinical research organization (CRO) with a trusted process for delivering reliable results, today announced it has released a new white paper titled, "The Innovation Imperative: How CROs Are Driving The...
Thursday, February 09, 2012
Almac is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility, built on a 40 acre site in Souderton, PA, north of Philadelphia, and occupied since 2010, delivers full-service, ...
Monday, February 13, 2012
Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals, announces the appointment of three non-executive directors to Cobra Biologics’ board, and two business development managers tasked with driving ...
Friday, February 17, 2012
Catalent Pharma Solutions today announced that it has completed the acquisition of the Clinical Trial Supplies business of Aptuit LLC. The acquisition substantially expands Catalent’s Development & Clinical Services business, transforming it into the...
Tuesday, February 21, 2012
Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal ...
Tuesday, February 21, 2012
Jubilant Biosys Limited, Bangalore announced today that they have entered into drug discovery collaboration with Mnemosyne Pharmaceutical Inc, Providence, Rhode Island that will seek to identify preclinical candidates in the area of neuropsychiatric ...